Singapore-based investor ABC Impact is set to make a strategic investment in AC Health, marking its first direct entry into the healthcare sector of the Philippines.
ABC Impact will acquire an approximately 16% minority stake in AC Health, with the primary capital investment being used to support the company’s aim of creating an integrated healthcare ecosystem to benefit the people of the country.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
This investment will strengthen AC Health’s growth across its core pillars, including hospitals, retail pharmacies and multi-speciality clinics.
AC Health plans to expand its network to at least ten hospitals, 300 clinics, and 1,150 pharmacies by 2027.
This expansion will be achieved through targeted acquisitions and organic growth, assisted by the new capital from ABC Impact.
With its focus on Asia, ABC Impact brings regional insights and networks to the partnership.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe investor has made healthcare investments in China, India, and Vietnam and sees potential for collaboration and knowledge-sharing that could enhance its care model in the Philippines.
AC Health president and CEO Paolo Borromeo said: “ABC Impact’s investment reinforces the strength of our integrated model and our commitment to making healthcare more inclusive.
“This partnership creates valuable opportunities for knowledge exchange, technology transfer, and the adoption of global best practices, further enabling AC Health to raise the bar in care quality, patient safety, and operational efficiency as it moves toward world-class standards.”
This move combines the integrated delivery network of AC Health with ABC Impact’s experience in investing in inclusive healthcare solutions.
ABC Impact also looks to build on its regional track record of purpose-driven capital infusions, which encompasses companies such as DCDC Kidney Care in India, Kim Dental in Vietnam, and clinical research organisation HiRo, which operates across the Asia Pacific and the US.
In addition, the move strengthens the partnership between the Ayala Group, which AC Health is a part of, and the Temasek ecosystem, which supports ABC Impact.
For this transaction, BofA Securities served as the exclusive financial adviser to AC Health. The completion of ABC Impact’s investment is contingent upon the fulfilment of closing conditions.
